A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional ...

A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant ...

A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated ...

A randomized clinical trial set up to assess if dalbavancin is superior to standard treatment for Staphylococcus aureus ...

USF Health and Tampa General Hospital collaborate on more efficient treatment of deadly infections Dr. Kami Kim is the ...

Among 200 patients, the probability of a more desirable day-70 outcome with two doses of intravenous dalbavancin versus 4 to 8 total weeks of standard therapy with an intravenous antibiotic was 47.7% ...

Researchers across 23 medical centers found a new two-dose treatment that could be as effective as standard treatment for complicated Staphylococcus aureus. The study was led by researchers from ...

Over-subscription of a topical antibiotic likely led to the emergence of a superbug which is now the leading cause of ...